Related Experiment Video

Updated: Jul 6, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

Management of hypertension in patients with left ventricular hypertrophy

Cesare Cuspidi1, Carla Sala, Alberto Zanchetti

  • 1Policlinico di Monza, Via Amati 111, 20052 Monza, Italy. cesare.cuspidi@unimib.it

Current Hypertension Reports
|March 28, 2008
PubMed

Insights

Left ventricular hypertrophy (LVH) is a key sign of organ damage in hypertension. Reversing LVH through combined drug therapy and lifestyle changes is crucial for improving outcomes in hypertensive patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Left ventricular hypertrophy (LVH) is a significant indicator of organ damage in patients with arterial hypertension.
  • Identifying LVH is essential due to its strong, independent adverse prognostic significance in hypertensive individuals.
  • LVH serves as an integrated marker of cardiovascular risk, reflecting the heart's response to hypertension's effects.

Purpose of the Study:

  • To emphasize the importance of identifying LVH in hypertensive patients.
  • To highlight LVH reversal as a key therapeutic goal in managing hypertension.
  • To outline effective pharmacologic and non-pharmacologic strategies for LVH regression.

Main Methods:

  • Review of clinical and epidemiologic studies on LVH in hypertension.
  • Analysis of pharmacologic strategies for LVH reversal.
  • Inclusion of non-pharmacologic interventions for promoting LVH regression.

Main Results:

  • LVH identification is fundamental in evaluating hypertensive patients.
  • LVH has a strong independent adverse prognostic significance.
  • Therapeutic strategies should combine renin-angiotensin system blockers with calcium antagonists or diuretics, alongside lifestyle changes.

Conclusions:

  • Reversing LVH is an intermediate goal of antihypertensive therapy.
  • Effective LVH regression requires combination pharmacologic therapy.
  • Non-pharmacologic interventions are vital components of successful therapeutic plans for LVH.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...